Home › Therapeutic areas › Neurology › Multiple Sclerosis
Multiple Sclerosis (10 companies)
Companies with an active program in Multiple Sclerosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | 12 |
| CLNN | Clene | Neurology Rare | 1 | NDA Submitted | 5 |
| IMUX | Immunic | GI/HepatologyNeurology | 2 | Phase 3 | 4 |
| KYTX | Kyverna Therapeutics | ImmunologyNeurology+1 Rare | 1 | NDA Submitted | 7 |
| NRIX | Nurix Therapeutics | ImmunologyNeurology+1 | 1 | Phase 2 | 15 |
| OCS | Oculis Holding | NeurologyOphthalmology | 1 | Phase 3 | 5 |
| TGTX | Tg Therapeutics | Neurology Rare | 3 | Approved | 4 |
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 1 | Approved | 26 |
| XNCR | Xencor | HematologyImmunology+4 Rare | 1 | Approved | 30 |
| ZBIO | Zenas BioPharma | DermatologyImmunology+1 Rare | 3 | NDA Submitted | 11 |
No companies match.